121 related articles for article (PubMed ID: 26264054)
1. In Silico Elucidation and Inhibition Studies of Selected Phytoligands Against Mitogen-Activated Protein Kinases of Protozoan Parasites.
Gupta CL; Akhtar S; Kumar N; Ali J; Pathak N; Bajpai P
Interdiscip Sci; 2016 Mar; 8(1):41-52. PubMed ID: 26264054
[TBL] [Abstract][Full Text] [Related]
2. In silico elucidation and inhibition studies of selected phytoligands against Mitogen activated protein kinases of protozoan parasites.
Gupta CL; Akhtar S; Kumar N; Ali J; Pathak N; Bajpai P
Interdiscip Sci; 2014 Nov; ():. PubMed ID: 25519156
[TBL] [Abstract][Full Text] [Related]
3. In silico elucidation and inhibition studies of selected phytoligands against Mitogen activated protein kinases of protozoan parasites.
Gupta CL; Akhtar S; Kumar N; Ali J; Pathak N; Bajpai P
Interdiscip Sci; 2014 Nov; ():. PubMed ID: 25373634
[TBL] [Abstract][Full Text] [Related]
4. Homology modeling of LmxMPK4 of Leishmania mexicana and virtual screening of potent inhibitors against it.
Gupta CL; Khan MK; Khan MF; Tiwari AK
Interdiscip Sci; 2013 Jun; 5(2):136-44. PubMed ID: 23740395
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase 4 of Leishmania parasite as a therapeutic target.
Saravanan P; Venkatesan SK; Mohan CG; Patra S; Dubey VK
Eur J Med Chem; 2010 Dec; 45(12):5662-70. PubMed ID: 20884088
[TBL] [Abstract][Full Text] [Related]
6. Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors.
Awale M; Kumar V; Saravanan P; Mohan CG
J Mol Model; 2010 Mar; 16(3):475-88. PubMed ID: 19649663
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases.
Osolodkin DI; Zakharevich NV; Palyulin VA; Danilenko VN; Zefirov NS
Parasitology; 2011 May; 138(6):725-35. PubMed ID: 21349219
[TBL] [Abstract][Full Text] [Related]
8. LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5.
John von Freyend S; Rosenqvist H; Fink A; Melzer IM; Clos J; Jensen ON; Wiese M
Int J Parasitol; 2010 Jul; 40(8):969-78. PubMed ID: 20178803
[TBL] [Abstract][Full Text] [Related]
9. Novel Insight from Computational Virtual Screening Depict the Binding Potential of Selected Phytotherapeutics Against Probable Drug Targets of Clostridium difficile.
Kamath S; Skariyachan S
Interdiscip Sci; 2018 Sep; 10(3):583-604. PubMed ID: 28217823
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of mitogen activated protein kinases in protozoan parasites.
Kaur P; Goyal N
Biochimie; 2022 Feb; 193():78-89. PubMed ID: 34706251
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
[TBL] [Abstract][Full Text] [Related]
12. Molecular interaction of selected phytochemicals under the charged environment of Plasmodium falciparum chloroquine resistance transporter (PfCRT) model.
Patel SK; Khedkar VM; Jha PC; Jasrai YT; Pandya HA; George LB; Highland HN; Skelton AA
J Biomol Struct Dyn; 2016; 34(2):290-303. PubMed ID: 25783783
[TBL] [Abstract][Full Text] [Related]
13. Exploring insights for virulent gene inhibition of multidrug resistant Salmonella typhi, Vibrio cholerae, and Staphylococcus areus by potential phytoligands via in silico screening.
Skariyachan S; Jayaprakash N; Bharadwaj N; Narayanappa R
J Biomol Struct Dyn; 2014; 32(9):1379-95. PubMed ID: 23876154
[TBL] [Abstract][Full Text] [Related]
14. Homology modeling and virtual screening for inhibitors of lipid kinase PI(4)K from Plasmodium.
Ren JX; Gao NN; Cao XS; Hu QA; Xie Y
Biomed Pharmacother; 2016 Oct; 83():798-808. PubMed ID: 27490781
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms.
Horjales S; Schmidt-Arras D; Limardo RR; Leclercq O; Obal G; Prina E; Turjanski AG; Späth GF; Buschiazzo A
Structure; 2012 Oct; 20(10):1649-60. PubMed ID: 22884419
[TBL] [Abstract][Full Text] [Related]
16. Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.
Liotta F; Siekierka JJ
Curr Opin Investig Drugs; 2010 Feb; 11(2):147-56. PubMed ID: 20112164
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds.
Sateriale A; Bessoff K; Sarkar IN; Huston CD
J Am Med Inform Assoc; 2014; 21(2):238-44. PubMed ID: 23757409
[TBL] [Abstract][Full Text] [Related]
18. Targeting Lysine Deacetylases (KDACs) in Parasites.
Wang Q; Rosa BA; Nare B; Powell K; Valente S; Rotili D; Mai A; Marshall GR; Mitreva M
PLoS Negl Trop Dis; 2015; 9(9):e0004026. PubMed ID: 26402733
[TBL] [Abstract][Full Text] [Related]
19. Protein kinases as targets for anti-parasitic chemotherapy.
Doerig C
Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
[TBL] [Abstract][Full Text] [Related]
20. Structural modeling and docking studies of ribose 5-phosphate isomerase from Leishmania major and Homo sapiens: a comparative analysis for Leishmaniasis treatment.
Capriles PV; Baptista LP; Guedes IA; Guimarães AC; Custódio FL; Alves-Ferreira M; Dardenne LE
J Mol Graph Model; 2015 Feb; 55():134-47. PubMed ID: 25528729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
